{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:19:50Z","timestamp":1788142790936,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06132-w","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:06:17Z","timestamp":1781874377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Direct oral anticoagulants versus vitamin K antagonists after left atrial appendage occlusion: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuanhua","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"5","key":"6132_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"key":"6132_CR2","doi-asserted-by":"publisher","unstructured":"Li X et al. Global burden and health inequality of atrial fibrillation\/atrial flutter from 1990 to 2021. Front Cardiovasc Med. 2025;12:1585980. https:\/\/doi.org\/10.3389\/fcvm.2025.1585980.","DOI":"10.3389\/fcvm.2025.1585980"},{"issue":"8","key":"6132_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study. Circulation. 2014;129(8):837\u201347.","journal-title":"Circulation"},{"issue":"2","key":"6132_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","volume":"61","author":"JL Blackshear","year":"1996","unstructured":"Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with AF. Ann Thorac Surg. 1996;61(2):755\u20139.","journal-title":"Ann Thorac Surg"},{"key":"6132_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DRJ Holmes","year":"2009","unstructured":"Holmes DRJ, et al. Percutaneous closure of the left atrial appendage vs warfarin therapy (PROTECT AF). Lancet. 2009;374:534\u201342.","journal-title":"Lancet"},{"key":"6132_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DRJ Holmes","year":"2014","unstructured":"Holmes DRJ, et al. Prospective randomized evaluation of the Watchman LAA closure device (PREVAIL). J Am Coll Cardiol. 2014;64:1\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"6132_CR7","first-page":"1103","volume":"12","author":"LV Boersma","year":"2016","unstructured":"Boersma LV, et al. Implant success and long-term outcomes of LAA closure: EWOLUTION registry. EuroIntervention. 2016;12(8):1103\u201311.","journal-title":"EuroIntervention"},{"key":"6132_CR8","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","volume":"143","author":"S Kar","year":"2021","unstructured":"Kar S, et al. Primary outcome evaluation of the next-generation Watchman FLX device (PINNACLE FLX). Circulation. 2021;143:1754\u201362.","journal-title":"Circulation"},{"issue":"2","key":"6132_CR9","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AF guideline. Circulation. 2019;140(2):e125\u201351.","journal-title":"Circulation"},{"issue":"3","key":"6132_CR10","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1378\/chest.126.3_suppl.204S","volume":"126","author":"J Ansell","year":"2004","unstructured":"Ansell J, et al. The pharmacology and management of the vitamin K antagonists. Chest. 2004;126(3):S204\u201333.","journal-title":"Chest"},{"key":"6132_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, et al. Dabigatran versus warfarin in patients with atrial fibrillation (RE-LY). N Engl J Med. 2009;361:1139\u201351.","journal-title":"N Engl J Med"},{"key":"6132_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF). N Engl J Med. 2011;365:883\u201391.","journal-title":"N Engl J Med"},{"key":"6132_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, et al. Apixaban versus warfarin in patients with atrial fibrillation (ARISTOTLE). N Engl J Med. 2011;365:981\u201392.","journal-title":"N Engl J Med"},{"key":"6132_CR14","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, et al. Edoxaban versus warfarin in atrial fibrillation (ENGAGE AF\u2013TIMI 48). N Engl J Med. 2013;369:2093\u2013104.","journal-title":"N Engl J Med"},{"issue":"11","key":"6132_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","volume":"12","author":"J Saw","year":"2019","unstructured":"Saw J, et al. Antithrombotic therapy and device-related thrombosis following LAA closure: meta-analysis. JACC Cardiovasc Interv. 2019;12(11):1067\u201376.","journal-title":"JACC Cardiovasc Interv"},{"key":"6132_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR, et al. Device-related thrombus after LAA closure: incidence, predictors, and outcomes. Circulation. 2018;138:874\u201385.","journal-title":"Circulation"},{"key":"6132_CR17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for atrial fibrillation. Circulation. 2024;149:e1\u2013145.","journal-title":"Circulation"},{"issue":"1","key":"6132_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10840-021-00958-4","volume":"64","author":"M Ajmal","year":"2022","unstructured":"Ajmal M, Hutchinson MD, Lee K, Indik JH. Outcomes in patients implanted with a Watchman device in relation to choice of anticoagulation and indication for implant. J Interventional Cardiac Electrophysiol. 2022;64(1):1\u20138.","journal-title":"J Interventional Cardiac Electrophysiol"},{"key":"6132_CR19","unstructured":"Apte NM, Comparing anti-coagulation strategies, in patients undergoing watchman implantation.. : incidence of periprocedural and 45-day thrombosis and bleeding."},{"issue":"7","key":"6132_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","volume":"13","author":"M Bergmann","year":"2017","unstructured":"Bergmann M, Betts T, Sievert H, Schmidt B, Pokushalov E, Kische S, Schmitz T, Meincke F, Stein K, Boersma L, et al. Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry. EuroIntervention. 2017;13(7):877\u201384.","journal-title":"EuroIntervention"},{"issue":"3","key":"6132_CR21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s11239-021-02408-4","volume":"52","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhang Y, Qu L, Huang W, Su X, Chen Y. Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure. J Thromb Thrombolysis. 2021;52(3):872\u20139.","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"6132_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/pace.13796","volume":"42","author":"JA Cohen","year":"2019","unstructured":"Cohen JA, Heist EK, Galvin J, Lee H, Johnson M, Fitzsimons M, Slattery K, Ghoshhajra B, Sakhuja R, Ha G, et al. A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantation. Pacing Clin Electrophysiol. 2019;42(10):1304\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"6132_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.hrthm.2016.10.020","volume":"14","author":"Y Enomoto","year":"2017","unstructured":"Enomoto Y, Gadiyaram VK, Gianni C, Horton RP, Trivedi C, Mohanty S, Di Biase L, Al-Ahmad A, Burkhardt JD, Narula A, et al. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device. Heart Rhythm. 2017;14(1):19\u201324.","journal-title":"Heart Rhythm"},{"issue":"18","key":"6132_CR24","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","volume":"79","author":"JV Freeman","year":"2022","unstructured":"Freeman JV, Higgins AY, Wang Y, Du C, Friedman DJ, Daimee UA, Minges KE, Pereira L, Goldsweig AM, Price MJ, et al. Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation. J Am Coll Cardiol. 2022;79(18):1785\u201398.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6132_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10840-020-00790-2","volume":"61","author":"E Fry","year":"2021","unstructured":"Fry E, Bollempali H, Suarez K, Banchs J, Michel J. Watchman outcomes comparing post-implantation anticoagulation with warfarin versus direct oral anticoagulants. J Interventional Cardiac Electrophysiol. 2021;61(1):137\u201344.","journal-title":"J Interventional Cardiac Electrophysiol"},{"issue":"8","key":"6132_CR26","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jfma.2021.10.015","volume":"121","author":"G Fu","year":"2022","unstructured":"Fu G, Wang B, He B, Yu Y, Wang Z, Feng M, Liu J, Du X, Zhuo W, Chu H. Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device. J Formos Med Assoc. 2022;121(8):1488\u201394.","journal-title":"J Formos Med Assoc"},{"issue":"S1","key":"6132_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/joa3.12267","volume":"35","author":"Atrial Fibrillation","year":"2019","unstructured":"Atrial Fibrillation. J Arrhythmia. 2019;35(S1):76\u2013327.","journal-title":"J Arrhythmia"},{"issue":"3","key":"6132_CR28","doi-asserted-by":"publisher","first-page":"003685042211131","DOI":"10.1177\/00368504221113194","volume":"105","author":"H Ge","year":"2022","unstructured":"Ge H, Zhang C, Qiao Z-Q, Hao Z-Y, Li Z, Gu Z-C, Jiang L-S, He B, Pu J. Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion. Sci Prog. 2022;105(3):00368504221113194.","journal-title":"Sci Prog"},{"key":"6132_CR29","doi-asserted-by":"publisher","first-page":"132875","DOI":"10.1016\/j.ijcard.2024.132875","volume":"421","author":"A Preda","year":"2025","unstructured":"Preda A, Falasconi G, Melillo F, Margonato D, Posteraro GA, Vella C, Marzi A, Guarracini F, Bella PD, Agricola E, et al. Left atrial appendage closure in patients with failure of anticoagulation therapy: A multicenter comparative study on the hybrid strategy using DOACs and VKAs. Int J Cardiol. 2025;421:132875.","journal-title":"Int J Cardiol"},{"issue":"6","key":"6132_CR30","doi-asserted-by":"publisher","first-page":"B1","DOI":"10.1016\/j.echo.2018.04.010","volume":"31","author":"2018 ASE 29th Annual scientific sessions","year":"2018","unstructured":"2018 ASE 29th Annual scientific sessions. J Am Soc Echocardiogr. 2018;31(6):B1\u2013142.","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"6132_CR31","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jacc.2024.05.067","volume":"84","author":"SW Reinhardt","year":"2024","unstructured":"Reinhardt SW, Gibson DN, Hsu JC, Kapadia SR, Yeh RW, Price MJ, Piccini JP, Nair DG, Christen T, Allocco DJ, et al. Anticoagulation alone vs anticoagulation plus aspirin or DAPT following left atrial appendage occlusion. J Am Coll Cardiol. 2024;84(10):889\u2013900.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6132_CR32","doi-asserted-by":"publisher","first-page":"e2214594","DOI":"10.1001\/jamanetworkopen.2022.14594","volume":"5","author":"F Su","year":"2022","unstructured":"Su F, Gao C, Liu J, Ning Z, He B, Liu Y, Xu Y, Yang B, Li Y, Zhang J, et al. Periprocedural outcomes associated with use of a left atrial appendage occlusion device in China. JAMA Netw Open. 2022;5(5):e2214594.","journal-title":"JAMA Netw Open"},{"key":"6132_CR33","doi-asserted-by":"crossref","unstructured":"Abstract. Catheterization and cardiovascular interventions. 2020, 95(S2).","DOI":"10.1002\/ccd.28864"},{"issue":"3","key":"6132_CR34","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.jscai.2022.100042","volume":"1","author":"BE-X Tan","year":"2022","unstructured":"Tan BE-X, Rao M, Baibhav B, Chuprun D, Shah A, Bhatt DL, Depta JP. Safety and efficacy of direct oral anticoagulants versus warfarin following WATCHMAN in high-risk patients. J Soc Cardiovasc Angiography Interventions. 2022;1(3):100042.","journal-title":"J Soc Cardiovasc Angiography Interventions"},{"issue":"3","key":"6132_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/24748706.2021.1890286","volume":"5","author":"B Tjoe","year":"2021","unstructured":"Tjoe B, Nguyen H, Mandava S, Quintos J, Li J, Yim S, Shafer C, Thompson C, Shenoda M, Cogert G, et al. Use of direct oral anticoagulation therapy following implantation of the watchman left atrial appendage occlusion device. Struct Heart. 2021;5(3):295\u2013301.","journal-title":"Struct Heart"},{"issue":"1","key":"6132_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-024-00834-7","volume":"26","author":"Y Yao","year":"2025","unstructured":"Yao Y, Jin Q, Zhang X, Lv Q. Clinical effectiveness and safety comparison between direct oral anticoagulants and warfarin for nonvalvular atrial fibrillation patients following percutaneous left atrial appendage closure operation intervention: a prospective observational study. BMC Pharmacol Toxicol. 2025;26(1):1.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"3","key":"6132_CR37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/jcm12030847","volume":"12","author":"X-D Zhou","year":"2023","unstructured":"Zhou X-D, Chen Q-F, Lin F, Wang L, Chen Y, Liang D, Huang W, Xiao F. Reduced- or half-dose rivaroxaban following left atrial appendage closure: a feasible antithrombotic therapy in patients at high risk of bleeding? J Clin Med. 2023;12(3):847.","journal-title":"J Clin Med"},{"key":"6132_CR38","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2147\/DDDT.S293812","volume":"15","author":"J Zhu","year":"2021","unstructured":"Zhu J, Xu J. The use of novel non-vitamin k antagonist oral anticoagulants following closure of the left atrial appendage: preliminary results of clinical follow-up. Drug Des Devel Ther. 2021;15:1067\u201373.","journal-title":"Drug Des Devel Ther"},{"key":"6132_CR39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jacc.2019.08.154","volume":"74","author":"P S\u00f8gaard","year":"2019","unstructured":"S\u00f8gaard P, et al. Antithrombotic therapy after left atrial appendage occlusion: a systematic review and meta-analysis. J Am Coll Cardiol. 2019;74:108\u201317.","journal-title":"J Am Coll Cardiol"},{"key":"6132_CR40","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1016\/S0735-1097(20)33799-2","volume":"75","author":"A Tzikas","year":"2020","unstructured":"Tzikas A, et al. Efficacy and safety of direct oral anticoagulants versus warfarin following left atrial appendage occlusion. J Am Coll Cardiol. 2020;75:3172\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"6132_CR41","first-page":"e009985","volume":"14","author":"J Saw","year":"2021","unstructured":"Saw J, et al. Direct oral anticoagulants versus warfarin for antithrombotic therapy after left atrial appendage occlusion. Circ Cardiovasc Interv. 2021;14:e009985.","journal-title":"Circ Cardiovasc Interv"},{"key":"6132_CR42","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955\u201362.","journal-title":"Lancet"},{"key":"6132_CR43","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, et al. 2016 ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2016;37:2893\u2013962.","journal-title":"Eur Heart J"},{"key":"6132_CR44","first-page":"1836","volume":"33","author":"J Wiebe","year":"2022","unstructured":"Wiebe J, et al. Antithrombotic therapy post-left atrial appendage occlusion: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2022;33:1836\u201345.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"6132_CR45","first-page":"2510","volume":"13","author":"MW Bergmann","year":"2020","unstructured":"Bergmann MW, et al. Left atrial appendage closure with the amulet device: 1-year follow-up. JACC Cardiovasc Interv. 2020;13:2510\u201321.","journal-title":"JACC Cardiovasc Interv"},{"key":"6132_CR46","first-page":"3348","volume":"73","author":"JF Viles-Gonzalez","year":"2019","unstructured":"Viles-Gonzalez JF, et al. Antithrombotic therapy following left atrial appendage occlusion: a review. J Am Coll Cardiol. 2019;73:3348\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"6132_CR47","first-page":"1478","volume":"14","author":"J Mainz","year":"2021","unstructured":"Mainz J, et al. Antithrombotic management after LAAO: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2021;14:1478\u201388.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"6132_CR48","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.1016\/j.crvasa.2018.05.001","volume":"60","author":"R \u010cih\u00e1k","year":"2018","unstructured":"\u010cih\u00e1k R, Haman L, T\u00e1borsk\u00fd M. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa. 2018;60(4):e421\u201346.","journal-title":"Cor et Vasa"},{"issue":"23","key":"6132_CR49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.21037\/atm.2017.09.19","volume":"5","author":"AA Khan","year":"2017","unstructured":"Khan AA, Lip GYH. Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. Annals Translational Med. 2017;5(23):465.","journal-title":"Annals Translational Med"},{"key":"6132_CR50","doi-asserted-by":"publisher","first-page":"101598","DOI":"10.1016\/j.ijcha.2025.101598","volume":"56","author":"M Yildirim","year":"2025","unstructured":"Yildirim M, Hund H, Mueller-Hennessen M, Katus HA, Frey N, Giannitsis E, Salbach C. Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry. IJC Heart Vasculature. 2025;56:101598.","journal-title":"IJC Heart Vasculature"},{"issue":"2","key":"6132_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40119-013-0019-y","volume":"2","author":"KH Ng","year":"2013","unstructured":"Ng KH, Hart RG, Eikelboom JW. Anticoagulation in patients Aged\u2009\u2265\u200975 years with atrial fibrillation: role of novel oral anticoagulants. Cardiol Therapy. 2013;2(2):135\u201349.","journal-title":"Cardiol Therapy"},{"issue":"4","key":"6132_CR52","doi-asserted-by":"publisher","first-page":"e036832","DOI":"10.1161\/JAHA.124.036832","volume":"14","author":"M Yildirim","year":"2025","unstructured":"Yildirim M, Milles BR, Hund H, Biener M, M\u00fcller-Hennessen M, Frey N, Katus HA, Giannitsis E, Salbach C. Outcomes and disease management in patients with atrial fibrillation\u2009\u2265\u200980 years: data from a consecutive 11-year real-world registry. J Am Heart Assoc. 2025;14(4):e036832.","journal-title":"J Am Heart Assoc"},{"key":"6132_CR53","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"6132_CR54","first-page":"734","volume":"95","author":"JA Sterne","year":"2005","unstructured":"Sterne JA, et al. Investigating and dealing with publication bias in meta-analysis. Br J Anaesth. 2005;95:734\u201340.","journal-title":"Br J Anaesth"},{"key":"6132_CR55","first-page":"205","volume":"11","author":"P Aagaard","year":"2018","unstructured":"Aagaard P, et al. Safety and efficacy of left atrial appendage occlusion in patients with atrial fibrillation and previous stroke. JACC Cardiovasc Interv. 2018;11:205\u201312.","journal-title":"JACC Cardiovasc Interv"},{"key":"6132_CR56","doi-asserted-by":"crossref","unstructured":"Higgins JPT, et al. Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell; 2019.","DOI":"10.1002\/9781119536604"},{"key":"6132_CR57","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/heartjnl-2020-317802","volume":"107","author":"T Shindo","year":"2021","unstructured":"Shindo T, et al. Geographic variations in anticoagulation therapy: impact on treatment outcomes. Heart. 2021;107:1054\u201362.","journal-title":"Heart"},{"key":"6132_CR58","first-page":"212","volume":"301","author":"M Abo-Aly","year":"2020","unstructured":"Abo-Aly M, et al. Antithrombotic regimens after left atrial appendage occlusion: a systematic review and meta-analysis. Int J Cardiol. 2020;301:212\u20139.","journal-title":"Int J Cardiol"},{"key":"6132_CR59","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/joic.12433","volume":"30","author":"SM Singh","year":"2017","unstructured":"Singh SM, et al. Antithrombotic regimen following LAAO: a systematic review and meta-analysis of 16,843 patients. J Interv Cardiol. 2017;30:234\u201342.","journal-title":"J Interv Cardiol"},{"key":"6132_CR60","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.jacc.2020.04.014","volume":"75","author":"G Yong","year":"2020","unstructured":"Yong G, et al. Regional differences in left atrial appendage occlusion outcomes. J Am Coll Cardiol. 2020;75:2523\u201333.","journal-title":"J Am Coll Cardiol"},{"key":"6132_CR61","first-page":"2135","volume":"16","author":"F Haghighi","year":"2018","unstructured":"Haghighi F, et al. Geographical and clinical heterogeneity in post-LAAO anticoagulation. J Thromb Haemost. 2018;16:2135\u201343.","journal-title":"J Thromb Haemost"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06132-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:02:40Z","timestamp":1788141760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06132-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6132"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06132-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data were obtained from publicly available databases; therefore, institutional review board approval and patient consent were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"754"}}